MAPT and early-onset autosomal dominant Alzheimer disease: These findings, combined with the LTD-enhancing effects of Alzheimer’s disease brain aqueous extracts (AD1, AD2) and Ts21 secretomes, confirm our hypothesis that patient brain-derived synaptotoxic tau facilitates hippocampal synaptic LTD.